Back
Omnicom Group Vs. Akero Therapeutics Industry Stock Comparison
Buy
64
OMC
Omnicom Group
Last Price:
96.01
Seasonality Move:
1.47%
Sell
28
AKRO
Akero Therapeutics
Last Price:
20.22
Seasonality Move:
16.15%
Buy
64
Omnicom Group (OMC)
is a Buy
Is Omnicom Group a Buy, Sell or Hold?
- The current Omnicom Group [OMC] share price is $94.22. The Score for OMC is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- OMC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $21.00. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OMC Stock Price Chart
What is Omnicom Group's stock price today?
-
The Omnicom Group share price today is $94.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OMC is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $21.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.
OMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 56.45 | Buy |
| Chaikin Money Flow: | 127489 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (91.77 - 94.99) | Buy |
| Bollinger Bands (100): | (85.28 - 92.92) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.18 | Sell |
| Relative Strength Index (14 RSI): | 35.31 | Sell |
| Chaikin Money Flow: | 33831 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.5 - 24.76) | Sell |
| Bollinger Bands (100): | (19.91 - 26.11) | Sell |
OMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 92.08 | Buy |
| 20-day SMA: | 93.26 | Buy |
| 50-day SMA: | 91.59 | Buy |
| 200-day SMA: | 84.2 | Buy |
| 8-day EMA: | 92.84 | Buy |
| 20-day EMA: | 92.77 | Buy |
| 50-day EMA: | 91.61 | Buy |
| 200-day EMA: | 86.8 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.3 | Sell |
| 20-day SMA: | 22.6 | Sell |
| 50-day SMA: | 24.68 | Sell |
| 200-day SMA: | 29.2 | Sell |
| 8-day EMA: | 21.33 | Sell |
| 20-day EMA: | 22.52 | Sell |
| 50-day EMA: | 23.52 | Sell |
| 200-day EMA: | 27.68 | Sell |
Omnicom Group Earnings Growth & OMC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.60 per share, and an increase next year of $0.56 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
Omnicom Group Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||